This inventor holds 1 USPTO granted patent. Top assignee: Iridex Corporation. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Benedetto Falsini: Innovator in Retinal Laser Treatment
Introduction
Benedetto Falsini is a notable inventor based in Rome, Italy. He has made significant contributions to the field of ophthalmology, particularly in the area of laser treatments for retinal conditions. His innovative approach combines technology and medical science to enhance patient care.
Latest Patents
Falsini holds a patent for a method and apparatus for controlling sub-clinical laser procedures with intra-operative monitoring of electrophysiological changes. This patent describes a method of monitoring and controlling sub-threshold laser treatment of a patient's retina. The system involves sensors placed on the patient to measure focal electroretinograms (FERG). A stimulating beam is delivered onto the patient's retina, and a pre-treatment FERG signal is collected. During the treatment, additional FERG signals are gathered while applying the sub-threshold laser. The difference between the pre-treatment and treatment FERG signals is then used to control the termination of the treatment.
Career Highlights
Falsini is currently associated with Iridex Corporation, where he continues to develop innovative solutions for retinal treatments. His work has been instrumental in advancing the understanding and application of laser technology in ophthalmology.
Collaborations
Falsini collaborates with various professionals in the field, including his coworker Giorgio Dorin. Their combined expertise contributes to the ongoing research and development of effective retinal treatment methods.
Conclusion
Benedetto Falsini's contributions to retinal laser treatment exemplify the intersection of innovation and healthcare. His patented methods are paving the way for improved patient outcomes in ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
